Samuel S. Dychter, MD
Senior Medical Director at Pfizer Inc.
Dr. Dychter has over 20 years of experience as a pharmaceutical physician starting his medical career as a general practitioner. He made the move into industry where he has worked at ICON Clinical Research, Maxim Pharmaceuticals, Chugai Pharma USA, Halozyme Therapeutics, and Fate Therapeutics in multiple therapeutic areas, with an emphasis in oncology and immunology. He has deep experience in the design and management of clinical trials, medical monitoring, safety/risk management, and medical affairs. Currently, Dr. Dychter is a Senior Medical Director and Clinical Program Leader for late-phase Immuno-oncology. Dr. Dychter is a graduate of the Faculty of Medicine of the National Autonomous University of Mexico with clinical training through the Mexican Institute of Social Security (IMSS) in Mexico City.